Large Private Equity Firm
Vice President, Healthcare Group Principal, Healthcare Group Associate
Launched
Multiple Myeloma
Subscribe to our newsletter to receive the latest case studies.
Large Private Equity Firm
Vice President, Healthcare Group Principal, Healthcare Group Associate
Launched
Multiple Myeloma
A large private equity firm was evaluating a potential investment in a diagnostics company with established products across Europe.
While the assets were already launched, future value depended on how reimbursement, procurement, and testing volumes would evolve across EU markets.
The firm engaged Alkemi to assess reimbursement structures, policy trends, and stakeholder dynamics in key countries to inform the overall attractiveness of the investment opportunity.
1. Conducted targeted desk research to understand reimbursement pathways, procurement models, and decision-makers across priority EU markets.
2. Interviewed local reimbursement and procurement stakeholders to validate pricing drivers, access barriers, and expected policy shifts.
3. Synthesized local insights into forward-looking reimbursement and volume trends to support investment modeling.
Provide decision-ready insight into how EU reimbursement dynamics would impact future value.
"Thanks again for pulling together a great team - we really appreciate it. Hope this is one of many engagements with us." - Vice President
Provided a grounded view of EU reimbursement and volume dynamics to support investment evaluation.
Reimbursement and volume insights informed more accurate revenue projections.
Helped the client assess market sustainability and downside risk before advancing the investment.